Variation in health-related quality of life (HRQOL) by line of therapy, age, and gender among patients with chronic lymphocytic leukemia. Predictive factors associated with achievement of major ...
Several biopharma companies are working on compounds to inhibit AKT, a protein kinase that has been implicated in many cancers. Researchers at Mount Sinai Hospital in New York are pursuing a different ...
An assessment of disease features and immune response in breast cancer patients that did not recur after receiving HER2 peptide, AE37 vaccine in a randomized phase II trial. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results